The HEMOPATCH brand, founded in 2012 (United States), from 241 sister brands and 4472 competing brands. HEMOPATCH is owned by Baxter International, listed on the stock exchange of New York HEMOPATCH belongs to the Medical Devices & Instruments business sector.
Investment simulator :
Portfolio valuation
Baxter International
(HEMOPATCH)
over 5 years*
USD 21.09